Retrophin, Inc. Names Margaret Valeur-Jensen GC

Retrophin, Inc. appointed Margaret Valeur-Jensen, Ph.D. to the newly created position of General Counsel. Valeur-Jensen joins Retrophin from Seed Intellectual Property Law Group PLLC. There, she served as Of Counsel in the Biotechnology, Pharmaceuticals and Chemistry Group. Previously, she was Executive Vice President and General Counsel of Neurocrine Biosciences, Inc. Earlier, she was Associate General Counsel Business Law Group of Amgen Inc., where she was responsible for licensing and corporate partnering, mergers and acquisitions, clinical development, sales and marketing, regulatory affairs, and real estate. Prior to joining Amgen, she was an associate at Davis, Polk & Wardwell.